Journal
POLYMERS FOR ADVANCED TECHNOLOGIES
Volume 18, Issue 4, Pages 329-333Publisher
JOHN WILEY & SONS LTD
DOI: 10.1002/pat.890
Keywords
carboxymethyl poly(L-histidine); pH-sensitive polypeptide; endosomal/lysosomal pH; drug delivery system
Categories
Ask authors/readers for more resources
A carboxymethyl poly(L-histidine) has been synthesized as a new pH-sensitive polypeptide at endosomal/lysosomal pH. Because of its poor water solubility at physiological pH, an application of poly(L-histidine) with a pK(a) around 6.0 has been limited in spite of the native possession of the pH-dependent property change at endosomal pH. Although the unmodified poly(L-histidine) suddenly precipitates out of the aqueous medium above pH 6.0 as the result of the deprotonation of the imidazole groups, the water solubility of the resulting carboxymethyl poly(L-histidine) has been improved at physiological pH. A solution turbidity measurement proved that no significant effect on a rapid aggregate formation or phase separation of serum proteins is induced by carboxymethyl poly(L-histidine). Hemolysis assay showed that the carboxymethyl poly(L-histidine) enhances membrane disruptive ability at endosomal/lysosomal pH. The cellular uptake of luciferase in the presence of the carboxymethyl poly(L-histidine) increases intracellular luciferase activity, which suggests that the carboxymethyl poly(L-histidine) makes the luciferase escape from lysosomal degradation. The carboxymethyl poly(L-histidine) would be the fundamental compound for designing various drug carriers with the pH sensitivity at endosomal/lysosomal pH. Copyright (C) 2007 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available